Tag: clinical trials

Source Data Archiving and Long-Term Integrity Under GCP

November 16, 2025 digi

Source Data Archiving and Long-Term Integrity Under GCP This comprehensive tutorial provides clinical operations, regulatory affairs, and medical affairs professionals with step-by-step guidance on the best practices surrounding source data archiving and ensuring long-term integrity under Good Clinical Practice (GCP) regulations. Special attention will be paid to the role of data safety monitoring boards (DSMB)…

Source Data & ALCOA++

KPIs for Deviation and Incident Management Performance in Clinical QMS

November 16, 2025November 15, 2025 digi

KPIs for Deviation and Incident Management Performance in Clinical QMS KPIs for Deviation and Incident Management Performance in Clinical Quality Management Systems Introduction to Key Performance Indicators (KPIs) in Clinical Trials In the realm of clinical research, the effectiveness of deviation and incident management is critical for ensuring the integrity of data and the safety…

Deviation/Incident Management

Close-Out Documentation That Satisfies Auditors and Inspectors

November 16, 2025November 15, 2025 digi

Close-Out Documentation That Satisfies Auditors and Inspectors Close-Out Documentation That Satisfies Auditors and Inspectors In clinical trials, the close-out phase concludes the research and is critical for ensuring compliance with regulations set by governing bodies such as the FDA, EMA, and MHRA. Proper close-out documentation serves as proof of compliance and is essential for any…

Close-Out Visits & Archiving

Managing Biobank and Sample Storage Commitments at Study End

November 16, 2025November 15, 2025 digi

Managing Biobank and Sample Storage Commitments at Study End In the complex landscape of clinical research, managing biobank and sample storage commitments at the study end can be a daunting task for professionals in clinical operations, regulatory affairs, and medical affairs. Effective management is crucial not only for regulatory compliance but also for ensuring that…

Close-Out Visits & Archiving

Using ALCOA++ Principles in Vendor and System Qualification

November 16, 2025November 15, 2025 digi

Using ALCOA++ Principles in Vendor and System Qualification In the context of clinical trials, the principles defined by ALCOA++ serve as critical guidelines for ensuring the integrity of data collection, processing, and reporting. This step-by-step tutorial provides a framework for clinical operations, regulatory affairs, and medical affairs professionals involved in the qualification of vendors and…

Source Data & ALCOA++

Training Site Staff on ALCOA++ Using Practical Examples

November 16, 2025November 15, 2025 digi

Training Site Staff on ALCOA++ Using Practical Examples Training Site Staff on ALCOA++ Using Practical Examples As clinical trials continue to evolve, the importance of ensuring data integrity extends beyond traditional practices. One such approach is the ALCOA++ principle, which emphasizes that source data must be Attributable, Legible, Contemporaneous, Original, Accurate, and complete. This step-by-step…

Source Data & ALCOA++

Case Studies: Deviation Management Gaps That Led to Warning Letters

November 16, 2025November 15, 2025 digi

Case Studies: Deviation Management Gaps That Led to Warning Letters Case Studies: Deviation Management Gaps That Led to Warning Letters Introduction to Deviation Management in Clinical Trials In the realm of clinical trials, effective deviation management is essential for maintaining compliance with regulatory requirements and ensuring the integrity of trial data. A clinical trial may…

Deviation/Incident Management

Remote Close-Out Models: When and How to Use Them

November 16, 2025November 15, 2025 digi

Remote Close-Out Models: When and How to Use Them In the rapidly evolving landscape of clinical research, the efficiency and effectiveness of close-out visits are pivotal for the successful completion of clinical trials. As globalization and technological advancements continue to transform the clinical trial ecosystem, remote close-out models have emerged as a practical solution. Particularly…

Close-Out Visits & Archiving

Lessons Learned Meetings After Close-Out to Improve Future Studies

November 16, 2025November 15, 2025 digi

Lessons Learned Meetings After Close-Out to Improve Future Studies Lessons Learned Meetings After Close-Out to Improve Future Studies In the complex world of clinical trials, particularly within the context of a sting agonist clinical trial, there lies an invaluable opportunity for reflection and improvement post-study. This article presents a comprehensive step-by-step tutorial guide on conducting…

Close-Out Visits & Archiving

Investigators’ Responsibilities for Source Data Review and Sign-Off

November 16, 2025November 15, 2025 digi

Investigators’ Responsibilities for Source Data Review and Sign-Off Clinical trials are critical for advancing medical knowledge and improving healthcare practices. As a clinical research professional, understanding the responsibilities of investigators, particularly in relation to source data review and sign-off, is paramount. This comprehensive guide will walk you through the responsibilities, best practices, and regulatory considerations…

Source Data & ALCOA++